federal register • 10 august 2020

CMS has published in the federal register:

  • A Final Rule for the Medicare Program: Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2021
  • A Notice of Agency Information Collection Activities
    1. Retiree Drug Subsidy (RDS) Application and Instructions
    2. Retiree Drug Subsidy Payment Request and Instructions
    3. Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals
    4. Consumer Experience Survey Data
  • A Notice of a Meeting: Advisory Panel on Hospital Outpatient Payment

federal register • 04 august 2020

CMS has published in the federal register:

  • A Final Rule for the Medicare Program: Fiscal Year 2021 Hospice Wage Index and Payment Rate Update
  • A Final Rule for the Medicare Program: Fiscal Year 2021 Inpatient Psychiatric Facilities Prospective Payment System and Special Requirements for Psychiatric Hospitals for Fiscal Year Beginning October 1, 2020
  • A Proposed Rule for the Medicare Program: Electronic Prescribing of Controlled Substances; Request for Information

federal register • 17 july 2020

CMS has published in the federal register:

  • A Notice of Agency Information Collection Activities:  Medication Therapy Management Program Improvements—Standardized Format
  • A Notice of Agency Information Collection Activities:
    1. Information Collection for Machine Readable Data for Provider Network and Prescription Formulary Content for FFM QHPs
    2. Beneficiary and Family Centered Data Collection
  • A Notice for the Medicare and Medicaid Programs: Application from the Joint Commission for Continued Approval of its Hospital Accreditation Program

federal register • 19 june 2020

CMS has published in the federal register:

  • A Final Rule on Nondiscrimination in Health and Health Education Programs or Activities: Delegation of Authority
  • A Proposed Rule for the Medicaid Program: Establishing Minimum Standards in  Medicaid State Drug Utilization Review and Supporting Value-Based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements